Sernova Biotherapeutics Inc
SVA.TO
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -76.56% | -92.82% | -69.74% | -84.60% | -76.50% |
| Total Receivables | -64.89% | -66.47% | -71.79% | -37.61% | 33.43% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.69% | -9.90% | -3.71% | 235.53% | 154.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -72.09% | -88.81% | -69.33% | -81.47% | -72.16% |
|
|
|||||
| Total Current Assets | -72.09% | -88.81% | -69.33% | -81.47% | -72.16% |
| Net Property, Plant & Equipment | -22.72% | -27.55% | 63.77% | 47.97% | 49.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -100.00% | -72.31% | -48.68% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.55% | -7.53% | -13.93% | -17.72% | -1.33% |
| Total Assets | -67.25% | -84.68% | -66.06% | -78.62% | -69.48% |
|
|
|||||
| Total Accounts Payable | 18.41% | 36.20% | 150.88% | 88.16% | 192.10% |
| Total Accrued Expenses | 14.33% | -11.15% | 5.99% | 146.79% | 124.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.47% | 11.38% | -25.71% | -42.07% | -40.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 38.48% | 33.96% | 107.97% | 87.27% | 182.33% |
|
|
|||||
| Total Current Liabilities | 38.48% | 33.96% | 107.97% | 87.27% | 182.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.72% | -25.53% | -- | 3,189.91% | 809.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.31% | 31.75% | 112.84% | 91.75% | 188.34% |
|
|
|||||
| Common Stock & APIC | 4.25% | -3.11% | 4.77% | -2.49% | 1.50% |
| Retained Earnings | -15.32% | -12.78% | -26.82% | -30.05% | -40.91% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -273.40% | -532.29% | -203.19% | -151.36% | -116.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -273.40% | -532.29% | -203.19% | -151.36% | -116.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -273.40% | -532.29% | -203.19% | -151.36% | -116.90% |
|
|
|||||